Anthony E Reeve
Overview
Explore the profile of Anthony E Reeve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blair V, McLeod M, Carneiro F, Coit D, DAddario J, van Dieren J, et al.
Lancet Oncol
. 2020 Aug;
21(8):e386-e397.
PMID: 32758476
Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused...
2.
Halliday B, Fukuzawa R, Markie D, Grundy R, Ludgate J, Black M, et al.
PLoS Genet
. 2018 Jun;
14(6):e1007399.
PMID: 29912901
Wilms tumour is a childhood tumour that arises as a consequence of somatic and rare germline mutations, the characterisation of which has refined our understanding of nephrogenesis and carcinogenesis. Here...
3.
Fukuzawa R, Anaka M, Morison I, Reeve A
PLoS One
. 2017 Oct;
12(10):e0186333.
PMID: 29040332
Wilms tumour (WT) is an embryonal tumour that recapitulates kidney development. The normal kidney is formed from two distinct embryological origins: the metanephric mesenchyme (MM) and the ureteric bud (UB)....
4.
McInnes T, Zou D, Rao D, Munro F, Phillips V, McCall J, et al.
BMC Cancer
. 2017 Mar;
17(1):228.
PMID: 28351398
Background: Aberrant DNA methylation profiles are a characteristic of all known cancer types, epitomized by the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC). Hypermethylation has been observed at...
5.
Ludgate J, Le Mee G, Fukuzawa R, Rodger E, Weeks R, Reeve A, et al.
Genes Chromosomes Cancer
. 2012 Oct;
52(2):174-84.
PMID: 23074036
Epigenetic abnormalities at the IGF2/H19 locus play a key role in the onset of Wilms tumor. These tumors can be classified into three molecular subtypes depending on the events occurring...
6.
Girardin A, McCall J, Black M, Edwards F, Phillips V, Taylor E, et al.
Int J Cancer
. 2012 Sep;
132(8):1842-50.
PMID: 23002055
Colorectal cancer is one of the five leading causes of cancer mortality worldwide. The mechanisms of pathogen clearance, inflammation and regulation by T cells in the healthy bowel are also...
7.
Kemp R, Black M, McCall J, Yoon H, Phillips V, Anjomshoaa A, et al.
J Exp Clin Cancer Res
. 2011 Aug;
30:78.
PMID: 21864372
Background: The immune response has been proposed to be an important factor in determining patient outcome in colorectal cancer (CRC). Previous studies have concentrated on characterizing T cell populations in...
8.
Fukuzawa R, Holman S, Chow C, Savarirayan R, Reeve A, Robertson S
J Med Genet
. 2010 Aug;
47(11):791-4.
PMID: 20679664
Background: Somatic mutations in the X-linked tumour suppressor gene WTX have been observed in 6- 30% of sporadic cases of Wilms tumour. Germline mutations in the same gene cause the...
9.
Lu A, Salpeter S, Reeve A, Eschrich S, Johnston P, Barrier A, et al.
Clin Colorectal Cancer
. 2009 Oct;
8(4):207-14.
PMID: 19822511
Purpose: The use of adjuvant therapy in stage II colorectal cancer (CRC) remains controversial. There is a need to identify more effective predictors than the traditional staging system to aid...
10.
Humar B, McNoe L, Dunbier A, Heathcott R, Braithwaite A, Reeve A
Biologics
. 2009 Aug;
2(2):329-37.
PMID: 19707365
Cyclooxygenase-2 (COX-2), the prostaglandin (PG)-synthesizing enzyme overexpressed in colorectal cancer (CRC), has pleiotropic, cancer-promoting effects. COX-2 inhibitors (CIBs) interfere with many cancer-associated processes and show promising antineoplastic activity, however, a...